Article
A molecular classification of gastric cancer associated with distinct clinical outcomes and validated by an XGBoost-based prediction model
26 Dec 2022
Abstract excerpt
Gastric cancer (GC) is a heterogeneous disease and a leading cause of cancer-related deaths. Discovering robust, clinically relevant molecular classifications is critical for guiding personalized therapies for GC. Here, we propose a refined molecular classification scheme for GC using integrated optimal algorithms and multi-omics data. Based on the important features of mRNA, microRNA, and DNA methylation data...
Topics
Join the communities discussing this publication.